These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18651809)

  • 21. An analysis of the in vitro mycostatic activity of some of the antifungal antibiotics on fungal strains isolated from patients treated with these antibiotics.
    Kurnatowska A; Kwasniewska J
    Mater Med Pol; 1978; 10(3):166-9. PubMed ID: 723290
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of Candida in inflammatory bowel disease. Estimation of transmission of C. albicans fungi in gastrointestinal tract based on genetic affinity between strains.
    Trojanowska D; Zwolinska-Wcislo M; Tokarczyk M; Kosowski K; Mach T; Budak A
    Med Sci Monit; 2010 Oct; 16(10):CR451-7. PubMed ID: 20885347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic mycoses in the 21st century.
    Graybill JR
    Infect Dis Clin North Am; 1995 Jun; 9(2):297-311. PubMed ID: 7673668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical practice: combination antifungal therapy for mold infections: much ado about nothing?
    Vazquez JA
    Clin Infect Dis; 2008 Jun; 46(12):1889-901. PubMed ID: 18466092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fungal infections in neonates: update on prevention and treatment.
    Kaufman DA
    Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonantifungal clinical drug interventions and human-commensal fungi: what are we selecting?
    Hull CM; Purdy NJ
    Future Microbiol; 2013 Jul; 8(7):813-6. PubMed ID: 23841625
    [No Abstract]   [Full Text] [Related]  

  • 28. [Is N,N,N,N,N,N-hexamethylphosphoric acid triamide (HMPT) suitable as universal solvent in testing of antifungal qualities].
    Lührs K
    Mykosen; 1970 May; 13(5):279-82. PubMed ID: 5475246
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental medical mycological research in Latin America - a 2000-2009 overview.
    San-Blas G; Burger E
    Rev Iberoam Micol; 2011; 28(1):1-25. PubMed ID: 21167301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N, N, N-trimethylamphotericin B methyl ester chloride (DMS-AME): in vitro and in vivo antifungal activity studies in comparison with fungizone.
    Zaremba M; Borowski J; Feliński J; Rozkiewicz D; Rozkiewicz M; Zaremba K; Czerwiński A; Borowski E
    J Chemother; 1989 Jul; 1(4 Suppl):243-5. PubMed ID: 16312386
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical relevance of resistance to antifungals.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Cuesta I; Alastruey-Izquierdo A; Monzon A; Mellado E; Cuenca-Estrella M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S111-3. PubMed ID: 19013333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward genome-enabled mycology.
    Hibbett DS; Stajich JE; Spatafora JW
    Mycologia; 2013; 105(6):1339-49. PubMed ID: 23928422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a molecular method for the diagnosis of medically important fungal infections.
    De Marco D; Perotti M; Ossi CM; Burioni R; Clementi M; Mancini N
    New Microbiol; 2007 Jul; 30(3):308-12. PubMed ID: 17802916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new problem: multiresistant fungi].
    Wehr A
    Dtsch Med Wochenschr; 1997 Mar; 122(11):A9. PubMed ID: 9102278
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibiting GPI anchor biosynthesis in fungi stresses the endoplasmic reticulum and enhances immunogenicity.
    McLellan CA; Whitesell L; King OD; Lancaster AK; Mazitschek R; Lindquist S
    ACS Chem Biol; 2012 Sep; 7(9):1520-8. PubMed ID: 22724584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive fungal infections: past achievements and challenges ahead.
    Arendrup MC
    Clin Microbiol Infect; 2009 Jul; 15(7):599-601. PubMed ID: 19673970
    [No Abstract]   [Full Text] [Related]  

  • 40. Sensitive and rapid polymerase chain reaction based diagnosis of mycotic keratitis through single stranded conformation polymorphism.
    Kumar M; Mishra NK; Shukla PK
    Am J Ophthalmol; 2005 Nov; 140(5):851-857. PubMed ID: 16310463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.